Clinical Trial Update: AL-54478 Proof of Concept Study [Phase 2]

View source ↗

Summary

Alcon Research reports a Phase 2 proof-of-concept study (NCT01318252) for AL-54478 in open-angle glaucoma and ocular hypertension; the trial status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AL-54478

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma (OAG), Ocular Hypertension (OHT) | Phase 2 | Status: COMPLETED